Happy news! Zhaoqing Dahuanong has passed the re-evaluation of "National Intellectual Property Demonstration Enterprise."

On October 13, 2022, the China National Intellectual Property Administration (CNIPA) announced the results of the re-evaluation of "National Intellectual Property Demonstration Enterprises and Advantage Enterprises." Zhaoqing Dahuanong Biological Pharmaceutical Co., Ltd. has successfully passed the re-evaluation and continues to retain the honorary title of "National Intellectual Property Demonstration Enterprise." This recognition reflects the company's commitment to innovation and the protection of intellectual property rights.

The title of "National Intellectual Property Demonstration Enterprise" is the highest honor in the field of enterprise intellectual property management in China. It is reported that after evaluation, preliminary review, and audit procedures, the China National Intellectual Property Administration has determined that a total of 875 National Intellectual Property Demonstration Enterprises and 3400 National Intellectual Property Advantage Enterprises have passed the re-evaluation.

Since its establishment, Dahuanong has always adhered to technological innovation and focused on the construction and cultivation of intellectual property. In 2013, it was rated as a "Zhaoqing Intellectual Property Pilot Enterprise," in 2015 as "Guangdong Intellectual Property Advantage Enterprise," and in 2016 it was the first to pass the GB/T29490-2013 Intellectual Property Management System Certification, which has been maintained to this day. In 2017, it was rated as "Guangdong Intellectual Property Demonstration Enterprise" and "National Intellectual Property Advantage Enterprise." In 2019, due to the excellent annual assessment results of "National Intellectual Property Advantage Enterprise," it was promoted to "National Intellectual Property Demonstration Enterprise" one year earlier. To date, Zhaoqing Dahuanong has applied for a total of 199 patents, including 149 invention patents, and has 101 valid patents, including 59 invention patents. It has won 2 China Patent Excellence Awards and 1 Guangdong Patent Gold Award.

The successful re-evaluation as a National Intellectual Property Demonstration Enterprise is a full affirmation and encouragement from the China National Intellectual Property Administration for the achievements made by Dahuanong in intellectual property innovation, management, and operation. In the future, Dahuanong will continue to improve and perfect its management system, effectively promote independent technological innovation, strengthen the scientific management and application of intellectual property, and provide protection for the company's long-term development.

Writing/ Gao Yan